Globus Medical (BSP:G2ME34) Cyclically Adjusted FCF per Share: R$0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:G2ME34 Globus Medical Inc BSP:G2ME34
26 GF Score
Price R$52.00
GF Value R$58.52
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Globus Medical Cyclically Adjusted FCF per Share?

Globus Medical BSP:G2ME34 26 Cyclically Adjusted FCF per Share is R$0.00 as of Jun. 2026. GuruFocus rates BSP:G2ME34 with a GF Score™ of 26/100 and a GF Value™ of R$58.52 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Note: As Cyclically Adjusted FCF per Share is a main component used to calculate Cyclically Adjusted Price-to-FCF. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Globus Medical's adjusted free cash flow per share for the three months ended in Jun. 2026 was R$6.586. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Globus Medical's average Cyclically Adjusted FCF Growth Rate was 26.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 16.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Globus Medical was 16.00% per year. The lowest was 11.20% per year. And the median was 11.90% per year.

As of today (2026-08-11), Globus Medical's current stock price is R$52.00. Globus Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was R$0.00. Globus Medical's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Globus Medical was 77.49. The lowest was 30.09. And the median was 48.08.


Globus Medical  (BSP:G2ME34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Globus Medical was 77.49. The lowest was 30.09. And the median was 48.08.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Globus Medical Cyclically Adjusted FCF per Share Related Terms


Globus Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Globus Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Cyclically Adjusted FCF per Share Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Globus Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSP:G2ME34 vs PODD, BRKR, GKOS: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted Price-to-FCF falls into.


BSP:G2ME34
26GF Score
Globus Medical Inc BSP:G2ME34
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Globus Medical's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.586/333.9520*333.9520
=6.586

Current CPI (Jun. 2026) = 333.9520.

Globus Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 1.217 241.428 1.683
201612 0.422 241.432 0.584
201703 1.349 243.801 1.848
201706 0.419 244.955 0.571
201709 0.704 246.819 0.953
201712 1.048 246.524 1.420
201803 1.303 249.554 1.744
201806 0.686 251.989 0.909
201809 1.470 252.439 1.945
201812 1.039 251.233 1.381
201903 0.419 254.202 0.550
201906 0.298 256.143 0.389
201909 1.767 256.759 2.298
201912 1.536 256.974 1.996
202003 0.956 258.115 1.237
202006 0.698 257.797 0.904
202009 1.930 260.280 2.476
202012 3.354 260.474 4.300
202103 2.745 264.877 3.461
202106 2.469 271.696 3.035
202109 3.006 274.310 3.660
202112 3.213 278.802 3.849
202203 1.182 287.504 1.373
202206 0.644 296.311 0.726
202209 1.083 296.808 1.219
202212 2.342 296.797 2.635
202303 1.902 301.836 2.104
202306 0.818 305.109 0.895
202309 1.241 307.789 1.346
202312 2.903 306.746 3.160
202403 0.876 312.332 0.937
202406 1.040 314.175 1.105
202409 6.486 315.301 6.870
202412 8.438 315.605 8.929
202503 5.817 319.799 6.074
202506 1.272 322.561 1.317
202509 8.089 324.800 8.317
202512 8.082 324.054 8.329
202603 6.159 330.213 6.229
202606 6.586 333.952 6.586

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of R$0.00 mean?
Globus Medical (BSP:G2ME34) has a Cyclically Adjusted FCF per Share of R$0.00 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Globus Medical and its competitors.
Is Globus Medical's Cyclically Adjusted FCF per Share too high?
Globus Medical's current Cyclically Adjusted FCF per Share is R$0.00. Overall, Globus Medical has a GF Score™ of 26/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Cyclically Adjusted FCF per Share compare to PODD and BRKR?
Globus Medical's Cyclically Adjusted FCF per Share of R$0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Globus Medical and its competitors. Globus Medical's current Cyclically Adjusted FCF per Share is R$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (BSP:G2ME34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$58.52, compared to a current price of R$52.00 — trading 11.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is R$0.00. Globus Medical's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Globus Medical (BSP:G2ME34), the current Cyclically Adjusted FCF per Share is R$0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (BSP:G2ME34) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of R$52.00 is trading 11.1% below its estimated GF Value™ of R$58.52. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for BSP:G2ME34:

  • Cyclically Adjusted FCF per Share: R$0.00
  • GF Value™: R$58.52 vs. price of R$52.00 (11.1% below fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the BSP:G2ME34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
26GF Score

Get the complete analysis for BSP:G2ME34

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.00
Price
R$58.52
GF Value